Cargando…

An interview with Dr Brad Spellberg

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209981/
https://www.ncbi.nlm.nih.gov/pubmed/34223019
http://dx.doi.org/10.1093/jacamr/dlaa062
_version_ 1783709223003095040
collection PubMed
description
format Online
Article
Text
id pubmed-8209981
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82099812021-07-02 An interview with Dr Brad Spellberg JAC Antimicrob Resist Educational Resource: Non-Commercial Oxford University Press 2020-08-11 /pmc/articles/PMC8209981/ /pubmed/34223019 http://dx.doi.org/10.1093/jacamr/dlaa062 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Educational Resource: Non-Commercial
An interview with Dr Brad Spellberg
title An interview with Dr Brad Spellberg
title_full An interview with Dr Brad Spellberg
title_fullStr An interview with Dr Brad Spellberg
title_full_unstemmed An interview with Dr Brad Spellberg
title_short An interview with Dr Brad Spellberg
title_sort interview with dr brad spellberg
topic Educational Resource: Non-Commercial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209981/
https://www.ncbi.nlm.nih.gov/pubmed/34223019
http://dx.doi.org/10.1093/jacamr/dlaa062